论文部分内容阅读
经导管动脉化疗栓塞治疗不能切除的肝癌,已广泛应用于临床,但能否延长病人的生存期仍无可靠证据。本文前瞻性研究同一时期、3个地区24个医疗中心、基本情况相似而不能切除的肝癌96例,随机分为化疗栓塞(CE)和保守(CM)治疗两组对照研究,旨在探索化疗栓塞治疗不能切除肝癌的临床意义。
Transcatheter arterial chemoembolization for the treatment of unresectable liver cancer has been widely used in clinical practice, but there is still no reliable evidence for prolonging the patient’s survival. This article prospectively studied 96 cases of liver cancer with similar basic and unresectable conditions in 24 medical centers in 3 regions at the same time, and were randomly divided into two groups: chemoembolization (CE) and conservative (CM) treatment to explore chemoembolization. The clinical significance of treatment of unresectable liver cancer.